Unleashing immuno-mass spectrometry superpowers to detect SARS-CoV-2 - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue EBioMedicine Année : 2021

Unleashing immuno-mass spectrometry superpowers to detect SARS-CoV-2

Résumé

In this article of EBioMedicine, Santosh Renuse and colleagues 1 show the relevance of combining immunoaffinity capture with targeted mass spectrometry measurement to detect SARS-CoV-2 nucleocapsid proteins in nasopharyngeal swab samples. The COVID-19 pandemic has confirmed the need to improve the toolbox available to diagnose respiratory infections. Rapid, reliable, and highly specific detection is essential if we are to mount immediate preventive and therapeutic responses. This report stands out from previous studies as it implements immunocapture along with robust validation for a large cohort of subjects. The results presented show that mass spectrometry is definitively at a crossroads for large-scale clinical applications.
Fichier principal
Vignette du fichier
Armengaud J 2021_eBiomedicine_immunoMS SARS-CoV-2.pdf (292.93 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-04460562 , version 1 (15-02-2024)

Identifiants

Citer

Jean Armengaud. Unleashing immuno-mass spectrometry superpowers to detect SARS-CoV-2. EBioMedicine, 2021, 69, pp.103480. ⟨10.1016/j.ebiom.2021.103480⟩. ⟨hal-04460562⟩
2 Consultations
6 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More